Dexamethasone targeted directly to macrophages induces macrophage niches that promote erythroid expansion

Haematologica

Volumn 100, Issue 2, 2015, Pages 178-187

  Falchi, Mario ^a   Varricchio, Lilian ^a   Martelli, Fabrizio ^a,b   Masiello, Francesca ^b   Federici, Giulia ^b,c   Zingariello, Maria ^d   Girelli, Gabriella ^d   Whitsett, Carolyn ^e   Petricoin, Emanuel F ^f   Moestrup, Søren Kragh ^g,h   Zeuner, Ann ^b   Migliaccio, Anna Rita ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f GEORGE MASON UNIVERSITY   (United States)

^g AARHUS UNIVERSITY   (Denmark)

^h UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; DEXAMETHASONE; ANTIINFLAMMATORY AGENT; CYTOKINE;

ANTIBODY RESPONSE; ARTICLE; CD34 SELECTION; CELL CULTURE; CELL CYCLE PROGRESSION; CELL EXPANSION; CELL INTERACTION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINESIS; ERYTHROCYTE PARAMETERS; ERYTHROID EXPANSION; ERYTHROPOIESIS; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MTT ASSAY; PROTEIN MICROARRAY; QUANTITATIVE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; VIDEO MICROSCOPY; WESTERN BLOTTING; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; DRUG EFFECTS; ERYTHROBLAST; FLOW CYTOMETRY; MACROPHAGE; METABOLISM; PHYSIOLOGY; TIME LAPSE IMAGING;

ANTI-INFLAMMATORY AGENTS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DEXAMETHASONE; ERYTHROBLASTS; ERYTHROPOIESIS; FLOW CYTOMETRY; HUMANS; MACROPHAGES; MICROSCOPY, VIDEO; TIME-LAPSE IMAGING;

EID: 84922135479     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2014.114405     Document Type: Article

References (44)

1. Gursoy A, Dogruk Unal A, et al. Polycythemia as the first manifestation of Cushing's disease. J Endocrinol Invest. 2006;29(8):742-744.
2. Bauer A, Tronche F, Wessely O, et al. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev. 1999;13(22): 2996-3002.
3. Dolznig H, Grebien F, Deiner EM, et al. Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR. Oncogene. 2006; 25(20):2890-2900.
4. Migliaccio G, Masiello F, Tirelli V, et al. Under HEMA conditions, self-replication of human erythroblasts is limited by autophag-ic death. Blood Cells Mol Dis. 2011;47 (3):182-197.
5. Varricchio L, Masselli E, Alfani E, et al. The dominant negative beta isoform of the glu-cocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients. Blood. 2011; 118(2):425-436.
6. Zhang L, Prak L, Rayon-Estrada V, et al. ZFP36L2 is required for self-renewal of early burst-forming unit erythroid progenitors. Nature. 2013; 499(7456):92-96.
7. Bessis M. L'ilot erythroblastique: unite func-tionelle de la moelle osseuse. Rev Hematol. 1958;13(1):8-11.
8. Mohandas N, Prenant M. Three-dimensional model of bone marrow. Blood. 1978; 51(4):633-643.
9. Rich IN, Heit W, Kubanek B. Extrarenal ery-thropoietin production by macrophages. Blood. 1982;60(4):1007-1018.
10. Rich IN. A role for the macrophage in normal hemopoiesis. I. Functional capacity of bone-marrow-derived macrophages to release hemopoietic growth factors. Exp Hematol. 1986;14(8):738-745.
11. Rhodes MM, Kopsombut P, Bondurant MC, Price JO, Koury MJ. Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin. Blood. 2008;111(3):1700-1708.
12. Temeles DS, McGrath HE, Kittler EL, et al. Cytokine expression from bone marrow derived macrophages. Exp Hematol. 1993; 21(2):388-393.
13. Hanspal M, Hanspal JS. The association of erythroblasts with macrophages promotes erythroid proliferation and maturation: a 30-kD heparin-binding protein is involved in this contact. Blood. 1994;84(10):3494-3504.
14. Chasis JA, Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood. 2008;112(3):470-478.
15. Manwani D, Bieker JJ. The erythroblastic island. Curr Top Dev Biol. 2008;82:23-53.
16. Vogt C, Noe G, Rich IN. The role of the blood island during normal and 5-fluo-rouracil-perturbed hemopoiesis. Blood Cells. 1991;17(1):105-121; discussion 21-25.
17. Ramos P, Casu C, Gardenghi S, et al. Macrophages support pathological erythro-poiesis in polycythemia vera and beta-tha-lassemia. Nat Med. 2013;19(4):437-445.
18. Chow A, Huggins M, Ahmed J, et al. CD169+ macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat Med. 2013;19(4):429-436.
19. Migliaccio AR, Migliaccio G, Adamson JW. Effect of recombinant hematopoietic growth factors on proliferation of human marrow progenitor cells in serum-deprived liquid culture. Blood. 1988; 72(4):1387-1392.
20. Labbaye C, Valtieri M, Barberi T, et al. Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis. J Clin Invest. 1995; 95(5):2346-2358.
21. von Lindern M, Zauner W, Mellitzer G, et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of ery-throid progenitors in vitro. Blood. 1999; 94(2):550-559.
22. Leberbauer C, Boulme F, Unfried G, Huber J, Beug H, Mullner EW. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood. 2005; 105(1): 85-94.
23. Migliaccio G, Di Pietro R, di Giacomo V, et al. In vitro mass production of human ery-throid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis. 2002;28(2):169-180.
24. Perry JM, Harandi O F, Paulson RF. BMP4, SCF, and hypoxia cooperatively regulate the expansion of murine stress erythroid progenitors. Blood. 2007;109(10):4494-4502.
25. Allen TD, Testa NG. Cellular interactions in erythroblastic islands in long-term bone marrow cultures, as studied by time-lapse video. Blood Cells. 1991;17(1):29-38; discussion 9-43.
26. Migliaccio AR, Whitsett C, Migliaccio G. Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr Opin Hematol. 2009;16(4):259-268.
27. Shapiro HM. Practical Flow Cytometry. 4th ed: Wiley-Liss, 2003.
28. Centurione L, Di Baldassarre A, Zingariello M, et al. Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1low mice. Blood. 2004; 104(12):3573-3580.
29. Improta G, Zupa A, Fillmore H, et al. Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation. J Proteome Res. 2011; 10(7):3089-3097.
30. Hricik T, Federici G, Zeuner A, et al. Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia vera. Am J Hematol. 2013;88 (9):723-729.
31. Stellacci E, Di Noia A, Di Baldassarre A, Migliaccio G, Battistini A, Migliaccio AR. Interaction between the glucocorticoid and erythropoietin receptors in human erythroid cells. Exp Hematol. 2009;37(5):559-572.
32. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008;132(4):631-644.
33. Spinner MA, Sanchez LA, Hsu A P, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123(6):809-821.
34. Migliaccio G, Migliaccio AR, Adamson JW. In vitro differentiation of human granulo-cyte/macrophage and erythroid progenitors: comparative analysis of the influence of recombinant human erythropoietin, G-CSF, GM-CSF, and IL-3 in serum-supplemented and serum-deprived cultures. Blood. 1988;72:248-256.
35. Lewis-Tuffin LJ, Jewell CM, Bienstock RJ, Collins JB, Cidlowski JA. Human glucocorti-coid receptor beta binds RU-486 and is tran-scriptionally active. Mol Cell Biol. 2007;27(6):2266-2282.
36. Ulyanova T, Jiang Y, Padilla SM, Papayannopoulou T. Erythroid cells generated in the absence of specific beta1-integrin heterodimers accumulate reactive oxygen species at homeostasis and are unable to mount effective antioxidant defenses. Haematologica. 2013;98(11):1769-1777.
37. Liu J, Zhang J, Ginzburg Y, et al. Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered ery-thropoiesis. Blood. 2013;121(8):e43-9.
38. Migliaccio G, Sanchez M, Masiello F, Tirelli V, Varricchio L, Whitsett C, Migliaccio AR. Humanized culture medium for clinical expansion of human erythroblasts. Cell Transplant. 2010;19(4):453-469.
39. Migliaccio AR. A niche for every cell, for every function. Haematologica 2013; 98:1660-1663.
40. Graversen JH, Svendsen P, Dagnaes-Hansen F, et al. Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone. Mol Ther. 2012;20(8): 1550-1558.
41. Yokoyama T, Etoh T, Kitagawa H, Tsukahara S, Kannan Y. Migration of ery-throblastic islands toward the sinusoid as erythroid maturation proceeds in rat bone marrow. J Vet Med Sci. 2003;65(4):449-52.
42. Vlachos A, Ball S, Dahl N, et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol. 2008; 142(6):859-876.
43. Lloberas J, Soler C, Celada A. Dexamethasone enhances macrophage colony stimulating factor- and granulocyte macrophage colony stimulating factor-stimulated proliferation of bone marrow-derived macrophages. Int Immunol. 1998; 10(5):593-599.
44. Lim HY, Muller N, Herold MJ, van den Brandt J, Reichardt HM. Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology. 2007;122(1):47-53.